Digital health coaching using wearable technology for chronic disease prevention

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on using digital health coaching combined with wearable technology to help individuals at risk of chronic diseases such as hypertension, obesity, and type 2 diabetes. Participants will receive personalized support and feedback through a smartwatch and a digital health coach, aiming to improve their lifestyle behaviors and prevent disease progression. The approach addresses the gaps in lifestyle interventions provided by healthcare professionals, particularly in Singapore, where chronic disease prevalence is high due to suboptimal lifestyle choices. The study employs a mixed-methods design to evaluate the effectiveness of this intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 21-75 years old
* Patients who are at risk of any of the following:

  1. Elevated blood pressure
  2. Overweight (BMI\>=23kg/m2)
  3. Pre-diabetes, OR
* Patients who have one or more of the following (HOLD) conditions:

  1. Hypertension
  2. Obesity (BMI\>=27.5kg/m2)
  3. HyperLipidemia
  4. Type 2 Diabetes Mellitus
* Patients who own a smartphone
* Patients who are willing to wear a smartwatch during the intervention period.

Exclusion Criteria:

* Patients who have a medical condition that prevented participation in physical activity
* Patients who have current diagnosis or history of eating disorder, depression
* Patients who are currently pregnant or planning to become pregnant in the next 6 months
* Patients who are currently participating in a weight loss programme (commercial, medically supervised, or research study)
* Patients who are on weight loss medications (over-the-counter or prescription)
* Patients who are not mentally-, physically- or technologically-capable
* Patients who is unable to provide informed consent.

Where it's running

• Alexandra Hospital
  Singapore, Singapore Recruiting

Study contacts

• Study coordinator: Elya Elya
• Email: ah_activation@nuhs.edu.sg
• Phone: 96505306

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Investigating body fat distribution and its impact on metabolic diseases in Japanese adults

  This study looks at how the way body fat is distributed affects the risk of metabolic and heart diseases in Japanese adults.

  Recruiting Osaka Metropolitan University · Sakai, Osaka · NCT06694012

• Isometric Handgrip Exercise for Older Adults with High Blood Pressure: A Feasibility Pilot

  This study tests whether a short, supervised handgrip program can be done safely in community settings by older adults with hypertension to see if it helps lower blood pressure and may boost cognitive function.

  Recruiting at 2 sites McMaster University · Hamilton, Ontario and 1 other locations · NCT07648498

• HJB647 in Japanese adults with elevated blood pressure and hypertension

  This study tests safety, tolerability, and how the body handles HJB647 after single and multiple doses in Japanese adults with elevated blood pressure and in patients with hypertension.

  Recruiting Phase 1 Novartis · Sumida Ku, Tokyo · NCT07644364

• Digital health platform to help prevent and manage high blood pressure, lipids, and kidney and heart disease

  This trial tests a mobile digital health platform to help people with hypertension, dyslipidemia, and related conditions in New Taipei City see if the platform improves blood pressure, cholesterol, and kidney health.

  Recruiting New Taipei City Medical Association · New Taipei City · NCT07588256

• Community-based exercise and lifestyle program for people at risk of metabolic syndrome

  A community program tests whether a structured exercise and lifestyle plan can improve heart and blood health in people with hypertension, high cholesterol, or high blood sugar.

  Recruiting Fu Jen Catholic University · New Taipei City · NCT07578090

• MOTS-c to improve insulin sensitivity in adults with prediabetes and overweight or obesity

  This 12-week test will see if the investigational peptide MOTS-c can improve insulin sensitivity in adults with prediabetes who are overweight or have obesity.

  Recruiting Phase 2 Hudson Biotech · Shenzhen, Guangdong · NCT07505745

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.